The current price is in 11,17$, Oyster Point Pharma Inc is a company created in United States dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in North America. Its Executives are Daniel Lochner (Chief Financial Officer), George Donato (Senior Vice President-Operations & CMC), Jeffrey A. Nau (President, Chief Executive Officer & Director), Marian Macsai (Chief Medical Officer & Head-Medical Affairs) and its address is 202 CARNEGIE CENTER SUITE 109, PRINCETON, New Jersey, 8540, United States.
The closing price of the stock yesterday was desconocido$.
With an intraday difference of 11,16$ moving between 11,12$ and 11,20$, it is a notable difference that allows quick purchases and sales.
Their latest annual data shows an income of desconocido.
The last value we have registered for the opening is desconocido.
If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].